Indications
Salbutamol + Budesonide inhaler is indicated for the treatment of asthma in patients who are 18 years of age and older, for the prevention of bronchoconstriction, and for reducing the risk of exacerbations in patients with asthma who are 18 years of age and older.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Salbutamol + Budesonide is a combination of salbutamol, a beta2-adrenergic agonist, and budesonide, a corticosteroid. It is used as needed to treat or prevent bronchoconstriction, and to lower the risk of exacerbations, in people with asthma who are 18 years of age and older. Salbutamol relaxes the smooth muscles of all the airways, from the trachea down to the terminal bronchioles. Budesonide works against many different cell types and mediators involved in inflammation.
Pregnancy & Breastfeeding
Pregnancy: No adequate and well-controlled studies of the Salbutamol + Budesonide inhaler have been done in pregnant women, so its risk in pregnancy is not known. Some information does exist for the two medicines separately. Epidemiological studies and postmarketing case reports of inhaled salbutamol use in pregnancy do not consistently show a risk of major birth defects or miscarriage. Reviews of budesonide use in pregnant women have not found a drug-related risk of major birth defects, miscarriage or other adverse outcomes for the mother or the baby.
Lactation: There are no data on how this inhaler affects a breastfed child or milk production.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.